PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Review Article

Volume 3 Issue 6

Early Stage of Breast Cancer can be Treated by Evidenced Based Herbal Drugs: A Scientific Analysis

Mohammad Nazrul Islam* and Bijoya Mithila

May 30, 2024

View PDF

Abstract

Breast cancer is a pandemic non-communicable disease in the world. In early stage, most of the women are neglecting the disease but in advanced stage it is incurable as well as fatal. So, it is needed to increase information, education and communication system to prevent the disease. There is no evidence based treatment available to treat the fatal disease. Some evidence based herbal drugs like Echinacea purpurea, Allium sativum, Dacus carrota, Camellia sinensis, Panax ginseng, Cimicifuga recemosa, Linum usitatissimum can be used to treat the disease in early stage and prevent progression of the disease.

References

  1. Brooks JD., et al. “Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy”. Am. J. Clin. Nutr 79 (2004): 318-325.
  2. Chen J, Stavro PM and Thompson LU. “Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor”. Nutr. Cancer 43 (2002): 187-192.
  3. Choi E., et al. “AKT1-targeted proapoptotic activity of compound K in human breast cancer cells”. Journal of Ginseng Research 43.4 (2019): 692-698.
  4. Dite GS., et al. “Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations”. J. Natl. Cancer Inst 95 (2003): 448-457.
  5. Donaldson MS. “Nutrition and cancer: a review of the evidence for an anti-cancer diet”. Nutr. J 20 (2004): 3-19.
  6. Edwards BK., et al. “Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden”. Cancer 94 (2002): 2766-2792.
  7. Ferlay J., et al. IARC; Lyon, France: 2000. GLOBOCAN (2000): Cancer Incidence, Mortality and Prevalence Worldwide IARC Cancer Base No 5.10.
  8. Freudenheim JL., et al. “Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients”. J. Natl. Cancer Inst 20.88 (1996): 340-348.
  9. Ham J., et al. “Genome-wide methylation analysis identifies NOX4 and KDM5A as key regulators in inhibiting breast cancer cell proliferation by ginsenoside Rg3”. The American Journal of Chinese Medicine 46.6 (2018): 1333-1355.
  10. Hong Y and Fan D. “Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells”. Toxicology 418 (2019): 22-31.
  11. Keum YS., et al. “Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed”. Cancer Lett 150 (2000): 41-48.
  12. Lambert JD and Yang CS. “Mechanisms of cancer prevention by tea constituents”. J. Nutr 133 (2003): 3262S-3267S.
  13. Lee H., et al. “Ginsenoside Rh2 epigenetically regulates cell-mediated immune pathway to inhibit proliferation of MCF-7 breast cancer cells”. Journal of Ginseng Research 42.4 (2018): 455-462.
  14. Liu Y and Fan D. “Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model”. Food & Function 9.11 (2018): 5513-5527.
  15. Luettig B., et al. “Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea”. J. Natl. Cancer Inst 3 (1989): 669-675.
  16. Oh J., et al. “The standardized Korean Red Ginseng extract and its ingredient ginsenoside Rg3 inhibit manifestation of breast cancer stem cell-like properties through modulation of self-renewal signaling”. Journal of Ginseng Research 43.3 (2019): 421-430.
  17. Parkin DM., et al. “Cancer Incidence in Five Continents”. IARC Scientific Publication No. 160, IARC, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France (1997).
  18. Porta C, Paglino C and Mosca A. “Targeting PI3K/Akt/mTOR signaling in cancer”. Frontiers in Oncology 4 (2014): 64.
  19. Rockwell S, Liu Y and Higgins SA. “Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh”. Breast Cancer Res. Treat 90 (2005): 233-239.
  20. Steffani ND. “The anti-carcinogenic effect of Echinacea purpurea and Echinacea pallida on a mammalian breast cancer cell line”. ETD Collection for Tennessee State University (2005): AAI3201864.
  21. Tan KP., et al. “Mammary gland morphogenesis is enhanced by exposure to flaxseed or its major lignan during suckling in rats”. Exp. Biol. Med. (Maywood) 229 (2004): 147-157.
  22. Wang P., et al. “Ginsenoside Rd attenuates breast cancer metastasis implicating derepressing microrna-18A-regulated smad2 expression”. Scientific Reports 6.1 (2016).
  23. WHO, 1981. World Health Organization Histological Typing of Breast Tumors, second ed. Geneva.
  24. Winston JC. “Health-promoting properties of common herbs”. Am. J. Clin. Nutr 70 (1999): 491-499.
  25. Wu SC., et al. “Cancer in North America, 1995-1999”. vol. III. North American Association of Central Cancer Registries; Springfield, IL: 2002. (NAACCR Combined Cancer Incidence Rates).
  26. Zaveri NT. “Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancerous applications”. Life Sci 78 (2006): 2073-2080.
  27. Zhang E., et al. “Ginsenoside Rd regulates the Akt/mTOR/p70S6K signaling cascade and suppresses angiogenesis and breast tumor growth”. Oncology Reports 38.1 (2017): 359-367.
  28. Zou M., et al. “Phosphoproteomic analysis of the antitumor effects of ginsenoside Rg3 in human breast cancer cells”. Oncology Letters 15.3 (2018): 2889-2898.